News

The company believes that the claims made in this litigation were without merit, and it did not admit liability. Currently, the diabetes drug will be available as a

IC, commonly referred to as painful bladder syndrome (PBS), is a chronic disease characterized by bladder pressure, bladder pain, urinary urgency and/or urinary frequency. It affects an estimated

The company said that this first-in-human trial is currently open at Horizon Oncology in Lafayette, Indiana, Sarah Cannon Research Institute in Nashville, Tennessee, the John Theurer Cancer Center

Navidea previously announced its intention to decrease its R&D expenses by divesting its non-core neuroimaging assets. This agreement follows through on the Company’s commitment to decrease cash burn

The acceptance of the NDA indicates the application is sufficiently complete to permit a substantive review by the FDA. "The FDA’s acceptance of our NDA filing brings us

"We are pleased that Triolimus has been designated an orphan drug for the treatment of angiosarcoma," commented Dr. Kevin Kozak, co-founder and Chief Medical Officer of Co-D Therapeutics.

Argatroban Injection is used to prevent or treat blood clots in adult patients who have developed antibodies to heparin or heparin-like products causing a decrease in platelets (known

Easton is pleased to announce that its first 3 main OTC products (Viorra, Skin Renou HA and Kenestrin Gel) are now ready to be ordered directly through its

Health Canada’s Natural and Non-Prescription Health Products Directorate (NNHPD) has issued natural product number (NPN), NPN 80060196 and NPN 80060197 with the claim that helps to maintain and